# Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

> **NCT04031599** · NA · COMPLETED · sponsor: **Institut de Recherches Cliniques de Montreal** · enrollment: 30 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Single-hormone closed-loop system
- **DEVICE:** Insulin pump
- **DEVICE:** Continuous glucose monitoring system
- **DRUG:** Aspart or Lispro
- **OTHER:** Carbohydrate counting
- **OTHER:** Simplified qualitative meal-size estimation strategy
- **OTHER:** 3-week intervention
- **OTHER:** 1-hour postprandial exercise (sub-study)
- **OTHER:** 2-hour postprandial exercise (sub-study)
- **OTHER:** Exercise announcement and meal bolus reduction (sub-study)

## Key facts

- **NCT ID:** NCT04031599
- **Lead sponsor:** Institut de Recherches Cliniques de Montreal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-10
- **Primary completion:** 2021-11-27
- **Final completion:** 2021-12-14
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04031599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04031599, "Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04031599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*